Titan Pharmaceuticals
TTNP
#11018
Rank
HK$48.1 M
Marketcap
HK$36.17
Share price
-3.76%
Change (1 day)
17.26%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.44. In 2023 the company made an earnings per share (EPS) of -HK$58.13 an increase over its 2022 EPS that were of -HK$119.17.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.13-51.22%
2022-HK$119.17-15.61%
2021-HK$141.21-81.37%
2020-HK$757.85-77.52%
2019-HK$3,372-56.32%
2018-HK$7,720-59.51%
2017-HK$19,068-371.81%
2016HK$7,015-144.35%
2015-HK$15,816300%
2014-HK$3,954-121.54%
2013HK$18,358-151.38%
2012-HK$35,727-11.54%
2011-HK$40,387188.89%
2010-HK$13,980-10%
2009-HK$15,534
2007-HK$63,688-2.38%
2006-HK$65,241-39.13%
2005-HK$107,182-16.87%
2004-HK$128,929-22.43%
2003-HK$166,2104.9%
2002-HK$158,44361.9%
2001-HK$97,862-13.7%
2000-HK$113,39665.01%
1999-HK$68,722-35.87%
1998-HK$107,164-1824.71%
1997HK$6,213-102.4%
1996-HK$259,412

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.53-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.07-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$31.77-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$7.22-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.88-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$33.42-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA